The fact that the PI3K pathway is activated universally in T cells in response to IL-2 involvement may explain why IL-2 secreted by CD4+ T cells at the tumor site induces CXCR3 expression in various T- cell subsets [50]. This evidence concerns the gene CXCR3 and neoplasm.